BriaCell Therapeutics Corp. (BCTX)

BriaCell Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is August - July.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 31, 2026	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022
Cash & Equivalents	9.85	10.49	0.86	21.25	41.04
Short-Term Investments	10.69	7.37	-	-	-
Cash & Short-Term Investments	20.54	17.87	0.86	21.25	41.04
Cash Growth	14.97%	1972.44%	-95.94%	-48.22%	-28.34%
Other Receivables	1.5	-	0.74	-	0.02
Receivables	1.5	-	0.74	-	0.02
Prepaid Expenses	-	2.06	2.06	5.7	1.28
Total Current Assets	22.04	19.93	3.65	26.95	42.35
Property, Plant & Equipment	0.32	0.3	0.39	-	-
Long-Term Investments	0.73	0.52	0.42	0	0
Other Intangible Assets	0.17	0.18	0.2	0.22	0.23
Other Long-Term Assets	0.32	0.72	1.21	-	-
Total Assets	23.58	21.65	5.87	27.16	42.58

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 31, 2026	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022
Accounts Payable	6.99	3.28	7.17	1.12	0.46
Accrued Expenses	0.99	0.69	0.29	0.68	0.48
Total Current Liabilities	7.98	3.98	7.46	1.8	0.94
Other Long-Term Liabilities	0.04	0.34	1.1	29.14	31.31
Total Liabilities	8.02	4.32	8.56	30.94	32.25

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 31, 2026	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022
Common Stock	120.91	101.74	72.17	69.59	65.59
Retained Earnings	-146.66	-111.76	-85.44	-80.65	-60.35
Comprehensive Income & Other	42.15	27.9	10.89	7.28	5.09
Total Common Equity	16.4	17.88	-2.38	-3.78	10.33
Minority Interest	-0.84	-0.55	-0.3	-	-
Shareholders' Equity	15.56	17.33	-2.68	-3.78	10.33
Total Liabilities & Equity	23.58	21.65	5.87	27.16	42.58

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 31, 2026	Jul 31, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022
Net Cash (Debt)	20.54	17.87	0.86	21.25	41.04
Net Cash Growth	14.97%	1972.44%	-95.94%	-48.22%	-28.30%
Net Cash Per Share	4.10	42.23	7.86	204.08	397.33
Filing Date Shares Outstanding	8.73	1.88	0.12	0.11	0.1
Total Common Shares Outstanding	8.71	1.88	0.12	0.11	0.1
Working Capital	14.06	15.95	-3.81	25.15	41.41
Book Value Per Share	1.88	9.49	-19.54	-35.45	99.84
Tangible Book Value	16.23	17.7	-2.58	-3.99	10.1
Tangible Book Value Per Share	1.86	9.39	-21.18	-37.47	97.61
Machinery	-	0.46	0.46	-	-

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error